May 17, 2012
The Editor-in-Chief has granted immediate free access to the articles below:
-
Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia
-
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
-
Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma
is feasible and highly effective: results of phase 1/2 open-label, dose escalation study
-
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative
neoplasm acute myeloid leukemia
-
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation
e-LETTERS
Most recent
ANNOUNCEMENTS
-
ASH Image Bank, Re-launched, Enhanced, and Free -
Announcing Blood 2.0 -
ASH launches Hematology Web Focus: a unique resource for clinicians -
Now available! ASH Self-Assessment Program Fourth Edition Standard (print with online access and online only) -
Blood now offers faster feedback through e-Letters -
Blood cited as one of the top 100 influential biology and medicine journals -
ASH’s alternative to NIH policy on public access
THREE MOST FREQUENTLY READ ARTICLES +more collections
